Instead, in smoking subjects with PAD, they found increased ATP and ADP levels together with increased CD39 activity compared to smoking subjects without PAD; the authors suppose that in absence of increased CD39 activity, smoking patients would have even higher ATP and ADP levels [76]. The gene discussed is ENTPD1; the disease is peripheral arterial disease.